Search Results - "Burkhardt, Harald"

Human MHC Class II and Invariant Chain Knock‐in Mice Mimic Rheumatoid Arthritis with Allele Restriction in Immune Response and Arthritis Association.

Authors: Romero‐Castillo, Laura Li, Taotao Do, Nhu‐Nguyen et al.

Source: Advanced Science; 6/19/2024, Vol. 11 Issue 23, p1-14, 14p

This result is not displayed to guests.
Login for full access.

This result is not displayed to guests.
Login for full access.

This result is not displayed to guests.
Login for full access.

This result is not displayed to guests.
Login for full access.

The sneaking ligand approach for cell type-specific modulation of intracellular signalling pathways.

Authors: Sehnert, Bettina Burkhardt, Harald Finzel, Stephanie et al.

Source: Clinical Immunology. Jan2018, Vol. 186, p14-20. 7p.

Cell-Type Targeted NF-kappaB Inhibition for the Treatment of Inflammatory Diseases.

Authors: Sehnert, Bettina Burkhardt, Harald Dübel, Stefan et al.

Source: Cells (2073-4409). Jul2020, Vol. 9 Issue 7, p1627. 1p.

NF-κB inhibitor targeted to activated endothelium demonstrates a critical role of endothelial NF-κB in immune-mediated diseases.

Authors: Sehnert, Bettina Burkhardt, Harald Wessels, Johannes T. et al.

Source: Proceedings of the National Academy of Sciences of the United States of America. 10/8/2013, Vol. 110 Issue 41, p16556-16561. 6p.

Subjects: Endothelium, Carcinogenesis, Cell proliferation, Autoimmune diseases, Transcription factors, Exotoxin

This result is not displayed to guests.
Login for full access.

This result is not displayed to guests.
Login for full access.

This result is not displayed to guests.
Login for full access.

Effectiveness of Different Rituximab Doses Combined with Leflunomide in the Treatment or Retreatment of Rheumatoid Arthritis: Part 2 of a Randomized, Placebo-Controlled, Investigator-Initiated Clinical Trial (AMARA).

Authors: Koehm, Michaela Foldenauer, Ann C. Rossmanith, Tanja et al.

Source: Journal of Clinical Medicine. Dec2022, Vol. 11 Issue 24, p7316. 13p.

Genetic variants in FBLIM1 gene do not contribute to SAPHO syndrome and chronic recurrent multifocal osteomyelitis in typical patient groups.

Authors: Assmann, Gunter Köhm, Michaela Schuster, Volker et al.

Source: BMC Medical Genetics. 5/12/2020, Vol. 21 Issue 1, p1-7. 7p.

New insights into the prevalence of depressive symptoms and depression in rheumatoid arthritis – Implications from the prospective multicenter VADERA II study.

Authors: Englbrecht, Matthias Alten, Rieke Aringer, Martin et al.

Source: PLoS ONE. 5/28/2019, Vol. 14 Issue 5, p1-13. 13p.

Cell adhesion-induced transient interaction of ADAM15 with poly(A) binding protein at the cell membrane colocalizes with mRNA translation.

Authors: Böhm, Beate B. Fehrl, Yuliya Janczi, Tomasz et al.

Source: PLoS ONE. 9/28/2018, Vol. 13 Issue 9, p1-25. 25p.

The role of antidrug antibodies in ustekinumab therapy and the impact of methotrexate.

Authors: Poor, Sorwe Mojtahed Henke, Marina Ulshöfer, Thomas et al.

Source: Rheumatology. Dec2023, Vol. 62 Issue 12, p3993-3999. 7p.

Lack of Evidence for Genetic Association to RUNX1 Binding Site at PSORS2 in Different German Psoriasis Cohorts.

Authors: Hüffmeier, Ulrike Traupe, Heiko Burkhardt, Harald et al.

Source: Journal of Investigative Dermatology. Jan2005, Vol. 124 Issue 1, p107-110. 4p.

Genome-wide association and targeted analysis of copy number variants with psoriatic arthritis in German patients.

Authors: Uebe, Steffen Ehrlicher, Maria Ekici, Arif Bülent et al.

Source: BMC Medical Genetics. 8/23/2017, Vol. 18 Issue 1, p1-10. 10p. 2 Diagrams, 3 Charts, 1 Graph.

GM-CSF in murine psoriasiform dermatitis: Redundant and pathogenic roles uncovered by antibody-induced neutralization and genetic deficiency.

Authors: Scholz, Tatjana Weigert, Andreas Brüne, Bernhard et al.

Source: PLoS ONE. 8/4/2017, Vol. 12 Issue 8, p1-19. 19p.

The role of YAP1 target gene CTGF in the anoikis resistance of rheumatoid arthritis synovial fibroblasts.

Authors: Janczi, Tomasz Fehrl, Yuliya Kinne, Raimund W et al.

Source: Rheumatology. Feb2023, Vol. 62 Issue 2, p850-860. 11p.